Uterine leiomyoma is associated with a polymorphism in the interleukin 1-β gene

American Journal of Reproductive Immunology

Volumn 62, Issue 2, 2009, Pages 112-117

  Pietrowski, Detlef ^a,b   Thewes, Roberta ^c   Sator, Michael ^a   Denschlag, Dominik ^c   Keck, Christoph ^d   Tempfer, Clemens ^a  

^a UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^b Fertilitaetszentrum Doebling ^*  (Austria)

^c UNIVERSITY OF FREIBURG   (Germany)

^d PAN Klinik am Neumarkt   (Germany)

Author keywords

Cytokines; Inflammation; Interleukin 1; Leiomyoma; Polymorphism; Tumor

Indexed keywords

INTERLEUKIN 1BETA;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UTERUS MYOMA;

CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-1BETA; LEIOMYOMA; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; UTERINE NEOPLASMS;

EID: 67650660669     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2009.00718.x     Document Type: Article

References (40)

1. Cramer SF, Patel A: The frequency of uterine leiomyomas. Am J Clin Pathol 1990; 94:435-438.
2. Morton CC: Warner-Lambert/Parke-Davis Award lecture. Many tumors and many genes: Genetics of uterine leiomyomata. Am J Pathol 1998; 153:1015-1020.
3. Di X, Yu L, Moore AB, Castro L, Zheng X, Hermon T, Dixon D: A low concentration of genistein induces estrogen receptor-alpha and insulin-like growth factor-I receptor interactions and proliferation in uterine leiomyoma cells. Hum Reprod 2008; 23:1873-1883.
4. Lethaby A, Vollenhoven B: Fibroids (uterine myomatosis, leiomyomas). Am Fam Physician 2005; 71:1753-1756.
5. Fauconnier A, Chapron C, Babaki-Fard K, Dubuisson JB: Recurrence of leiomyomata after myomectomy. Hum Reprod Update 2000; 6:595-602.
6. Malyshkina AI, Posiseeva LV, Sotnikova NY, Antsiferova JS, Suvorkina EE, Arevadze IE: Local immunological markers of different rate of growth of uterine myoma. Russ J Immunol 2002; 7:58-62.
7. Yun AJ, Daniel SM: Sympathetic and T helper (Th)2 bias may ameliorate uterine fibroids, independent of sex steroids. Med Hypotheses 2005; 65:1172-1175.
8. Bataille R, Chappard D, Klein B: The critical role of interleukin-6, interleukin-1β and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma. Int J Clin Lab Res 1992; 21:283-287.
9. Kamangar F, Cheng C, Abnet CC, Rabkin CS: Interleukin-1β polymorphisms and gastric cancer risk - a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15:1920-1928.
10. ChIrch LD, Cook GP, McDermott MF: Primer: inflammasomes and interleukin 1beta in inflammatory disorders. Nat Clin Pract Rheumatol 2008; 4:34-42.
11. Hsieh YY, Chang CC, Tsai CH, Lin CC, Tsai FJ: Interleukin (IL)-12 receptor beta1 codon 378G homozygote and allele, but not IL-1 (beta-511 promoter, 3953 exon 5, receptor antagonist), IL-2 114, IL-4-590 intron 3, IL-8 3′-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma. Fertil Steril 2007; 87:886-895.
12. Ding Z, Xiong K, Issekutz TB: Regulation of chemokine-induced transendothelial migration of T lymphocytes by endothelial activation: differential effects on naive and memory T cells. J Leukoc Biol 2000; 67:825-833.
13. Issekutz AC: Adhesion molecules mediating neutrophil migration to arthritis in vivo and across endothelium and connective tissue barriers in vitro. Inflamm Res 1998; 47 (Suppl. 3):S123-S132.
14. Pociot F, Mølvig J, Wogensen L, Worsaae H, Nerup J: A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992; 22:396-402.
15. Sparre T, Christensen UB, Gotfredsen CF, Larsen PM, Fey SJ, Hjernø K, Roepstorff P, Pociot F, Karlsen AE, Nerup J: Changes in expression of IL-1 beta influenced proteins in transplanted islets during development of diabetes in diabetes-prone BB rats. Diabetologia 2004; 47:892-908.
16. Tsai FJ, Hsieh YY, Chang CC, Lin CC, Tsai CH: Polymorphisms for interleukin 1 beta exon 5 and interleukin 1 receptor antagonist in Taiwanese children with febrile convulsions. Arch Pediatr Adolesc Med 2002; 156:545-548.
17. Huang CM, Tsai FJ, Wu JY, Wu MC: Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in rheumatoid arthritis. Scand J Rheumatol 2001; 30:225-228.
18. Guzeldemir E, Gunhan M, Ozcelik O, Tastan H: Interleukin-1 and tumor necrosis factor-alpha gene polymorphisms in Turkish patients with localized aggressive periodontitis. J Oral Sci 2008; 50:151-159.
19. Denschlag D, Bentz EK, Hefler L, Pietrowski D, Zeillinger R, Tempfer C, Tong D: Genotype distribution of estrogen receptor-alpha, catechol-O-methyltransferase, and cytochrome P450-17 gene polymorphisms in Caucasian women with uterine leiomyomas. Fertil Steril 2006; 85:462-467.
20. Herr D, Keck C, Bettendorf H, Denschlag D, Pietrowski D: Association of TNF-α gene polymorphisms with the occurrence of uterine leiomyoma. Assoziation von TNF-α Gen-Polymorphismen mit dem Auftreten von Leiomyomen des Uterus. Geburtshilfe Frauenheilkd 2007; 67:38-42.
21. Hadfield RM, Manek S, Weeks DE, Mardon HJ, Barlow DH, Kennedy SH, OXEGENE Collaborative Group: Linkage and association studies of the relationship between endometriosis and genes encoding the detoxification enzymes GSTM1, GSTT1 and CYP1A1. Mol Hum Reprod 2001; 7:1073-1078.
22. Nakago S, Hadfield RM, Zondervan KT, Mardon H, Manek S, Weeks DE, Barlow D, Kennedy S: Association between endometriosis and N-acetyl transferase 2 polymorphisms in a UK population. Mol Hum Reprod 2001; 7:1079-1083.
23. FantiFi MC, Pallone F: Cytokines: from gut inflammation to colorectal cancer. Curr Drug Targets 2008; 9:375-380.
24. Pope RM, Tschopp J: The role of interleukin-1 and the inflammasome in gout: Implications for therapy. Arthritis Rheum 2007; 56:3183-3188.
25. Rao M, Wong C, Kanetsky P, Girndt M, Stenvinkel P, Reilly M, Raj DS: Cytokine gene polymorphism and progression of renal and cardiovascular diseases. Kidney Int 2007; 72:549-556.
26. Diamanti-Kandarakis E, Paterakis T, Kandarakis HA: Indices of low-grade inflammation in polycystic ovary syndrome. Ann NY Acad Sci 2006; 1092:175-186.
27. Oksenberg JR, Baranzini SE, Sawcer S, Hauser SL: The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet 2008; 9:516-526.
28. Cho JH: The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 2008; 8:458-466.
29. Skubitz KM, Skubitz AP: Differential gene expression in uterine leiomyoma. J Lab Clin Med 2003; 141:297-308.
30. Evans P, Brunsell D: Uterine fibroid tumors: diagnosis and treatment. Am Fam Physician 2007; 75:1503-1508.
31. Litovkin KV, Domenyuk VP, Bubnov VV, Zaporozhan VN: Interleukin-6-174G/ C polymorphism in breast cancer and uterine leiomyoma patients: A population-based case control study. Exp Oncol 2007; 29:295-298.
32. Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz GA, Willett WC, Hunter DJ: Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 1997; 90:967-973.
33. Camargo MC, Mera R, Correa P, Peek RM Jr, Fontham ET, Goodman KJ, Piazuelo MB, Sicinschi L, Zabaleta J, Schneider BG: Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: A meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15:1674-1687.
34. Loh M, Koh KX, Yeo BH, Song CM, Chia KS, Zhu F, Yeoh KG, Hill J, Iacopetta B, Soong R: Meta-analysis of genetic polymorphisms and gastric cancer risk: Variability in associations according to race. Eur J Cancer 2009; doi: [Epub ahead of print].
35. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr, Rabkin CS: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404:398-402.
36. Lee KA, Ki CS, Kim HJ, Sohn KM, Kim JW, Kang WK, Rhee JC, Song SY, Sohn TS: Novel interleukin 1beta polymorphism increased the risk of gastric cancer in a Korean population. J Gastroenterol 2004; 39:429-433.
37. Chang YW, Jang JY, Kim NH, Lee JW, Lee HJ, Jung WW, Dong SH, Kim HJ, Kim BH, Lee JI, Chang R: Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1beta cytokine in Korean patients with gastric cancer. Int J Cancer 2005; 114:465-471.
38. Hulkkonen J, Laippala P, Hurme M: A rare allele combination of the interleukin-1 gene complex is associated with high interleukin-1 beta plasma levels in healthy individuals. Eur Cytokine Netw 2000; 11:251-255.
39. Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C, Rogus J, Beck JD, Offenbacher S, Cork MJ, Rafie-Kolpin M, Hsieh CM, Kornman KS, Duff GW: Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 2006; 15:519-529.
40. Belfer I, Buzas B, Hipp H, Dean M, Evans C, Lorincz I, Max MB, Goldman D: Haplotype structure of inflammatory cytokines genes (IL1B, IL6 and TNF/LTA) in US Caucasians and African Americans. Genes Immun 2004; 5:505-512.